should glp-1 agonists be open access

should glp-1 agonists be open access Mapping the effectiveness and risks of receptor How should GLP-1 receptor agonists

Name: should glp-1 agonists be open access Mapping the effectiveness and risks of receptor How should GLP-1 receptor agonists
Brand: buller-pirmasens.de
SKU: 60615828777
Price: 23.39 USD
Availability: InStock
Rating: 4.615600000000001 (17 reviews)

SKU: 60615828777

4.6

EUR23.39 EUR55.39

Pay in 4 interest-free payments of $5.85 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 11 - Oct 16

Description

The weight of any such item can be found on its detail page

doi: 10.1146/annurev-vision-121219-081730 165 YumnamchaTDeviTSSinghLP

2011 Sep;94(3):84753

The anthocyanin delphinidin 3-rutinoside stimulates glucagon-like peptide-1 secretion in murine GLUTag cell line via the Ca 2+ /calmodulin-dependent kinase II pathway

CS: Writing review & editing, Writing original draft, Resources

This is significant because current lupus nephritis management relies heavily on immunosuppressants (mycophenolate, cyclophosphamide, voclosporin) and biologics (belimumab, rituximab)